NCT00041678

Brief Summary

The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jan 2000

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2000

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

July 12, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 15, 2002

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2003

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2003

Completed
Last Updated

November 11, 2013

Status Verified

September 1, 2007

Enrollment Period

3.2 years

First QC Date

July 12, 2002

Last Update Submit

November 7, 2013

Conditions

Alzheimer Disease

Keywords

Psychosis Associated with Dementia of the Alzheimer's Type

Interventions

aripiprazoleDRUG

Eligibility Criteria

Age55 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Institutionalized patients with Alzheimer's Disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Local Institution

Rosemead, California, United States

Location

Local Institution

Miami, Florida, United States

Location

Local Institution

Nashville, Tennessee, United States

Location

Local Institution

Bennington, Vermont, United States

Location

Local Institution

Burlington, Vermont, United States

Location

Local Institution

Milwaukee, Wisconsin, United States

Location

MeSH Terms

Conditions

Alzheimer Disease

Interventions

Aripiprazole

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PiperazinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsQuinolonesQuinolinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Design

Study Type
interventional
Phase
phase 3
Purpose
TREATMENT
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

July 12, 2002

First Posted

July 15, 2002

Study Start

January 1, 2000

Primary Completion

March 1, 2003

Study Completion

March 1, 2003

Last Updated

November 11, 2013

Record last verified: 2007-09

Locations

US(6)